A series of novel 1,3,4-oxadiazole thioether derivatives (compounds 9-44) were designed and synthesized as potential inhibitors of thymidylate synthase (TS) and as anticancer agents. The in vitro anticancer activities of these compounds were evaluated against three cancer cell lines by the MTT method. Among all the designed compounds, compound 18 bearing a nitro substituent exhibited more potent in vitro anticancer activities with IC50 values of 0.7 +/- 0.2, 30.0 +/- 1.2, 18.3 +/- 1.4 mu M, respectively, which was superior to the positive control. In the further study, it was identified as the most potent inhibitor against two kinds of TS protein (for human TS and Escherichia coli TS, IC50 values: 0.62 and 0.47 mu M, respectively) in the TS inhibition assay in vitro and the most potent antibacterial agents with MIC (minimum inhibitory concentrations) of 1.56-3.13 mu g/mL against the tested four bacterial strains. Molecular docking and 3D-QSAR study supported that compound 18 can be selected as dual antitumor/antibacterial candidate in the future study. (C) 2013 Elsevier Ltd. All rights reserved.
A series of 2-(benzylthio)-5-aryloxadiazole derivatives have been designed and synthesized, and their biological activities are also evaluated for EGFR inhibitory activity. Fourteen compounds among the twenty compounds are reported for the first time. Their chemical structures are characterized by 1H NMR, MS, and elemental analysis. Anti-proliferative and EGFR inhibition assay results have demonstrated
13C NMR chemical shifts of the carbon atoms of the methoxymethyl group of di-ortho-substituted aromatic methoxymethyl ethers
作者:Teodoro S. Kaufman、Robert D. Sindelar、Alex R. Jürgens
DOI:10.1002/mrc.1260271213
日期:1989.12
Complete 13C spectral assignments of 28 aromatic methoxymethyl ethers bearing different substituents and substitution patterns were made. While meta-, para- or mono-ortho-substitution did not significantly affect the 13C resonances of the carbon atoms of the methoxymethyl group, di-ortho-substitution produced the deshielding of both carbons. This effect was more pronounced on the methylene carbon atom.
Asymmetric Allylic C–H Alkylation via Palladium(II)/<i>cis</i>-ArSOX Catalysis
作者:Wei Liu、Siraj Z. Ali、Stephen E. Ammann、M. Christina White
DOI:10.1021/jacs.8b05668
日期:2018.8.29
asymmetric C-H alkylation of terminal olefins with a variety of synthetically versatile nucleophiles. The modular, tunable, and oxidatively stable ArSOX scaffold is key to the unprecedented broad scope and high enantioselectivity (37 examples, avg. > 90% ee). Pd(II)/ cis-ArSOX is unique in its ability to effect high reactivity and catalyst-controlled diastereoselectivity on the alkylation of aliphatic
Provided are methods and compositions for the treatment of diseases such as cancer. In certain aspects, compounds which can inhibit Skp2 are provided. Specifically chromenone derivatives are disclosed that have the capability toward reducing differentiation of pluripotent, multipotent or totipotent cells and thus have therapeutic utility in the treatment of a proliferative disease such as cancer.
Synthesis of Phenanthrene Derivatives by Intramolecular Cyclization Utilizing the [1,2]-Phospha-Brook Rearrangement Catalyzed by a Brønsted Base
作者:Azusa Kondoh、Takuma Aoki、Masahiro Terada
DOI:10.1002/chem.201501377
日期:2015.9.1
The synthesis of functionalized phenanthrene derivatives was achieved by intramolecular cyclization utilizing the [1,2]‐phospha‐Brook rearrangement under Brønsted base catalysis. Treatment of biaryl compounds having an α‐ketoester moiety and an alkyne moiety at the 2 and 2′ positions, respectively, with diisopropyl phosphite in the presence of a catalytic amount of phosphazene base P2‐tBu provides
功能化的菲衍生物的合成是通过在Brønsted碱催化下利用[1,2]-磷-布鲁克重排进行分子内环化来实现的。在催化量的磷腈碱P2 - t Bu存在下,用亚磷酸二异丙酯处理在2和2'位置分别具有α-酮酸酯部分和炔烃部分的联芳基化合物,可以得到9,10-二取代的菲衍生物。高产。该反应涉及通过乌珀隆过程生成酯烯酸酯,即将亚磷酸二异丙酯添加至酮部分,然后进行[1,2]-磷-布鲁克重排,将分子内添加至炔烃,以及[3] ,3]以连续方式重新排列烯丙基磷酸酯部分。